Protein misfolding and aggregation are responsible for several human pathologies commonly known as protein misfolding diseases. The current research work was carried out to investigate the potential of ZnO nanoparticle to prevent lysozyme aggregation. ZnO nanoparticles were synthesized by chemical precipitation method and characterized using different biophysical techniques. The lysozyme aggregation was prepared by heating the native lysozyme at 100 degee Celsius. The effect of ZnO nanoparticles on the aggregation of lysozyme was studied using different biophysical techniques. DLS analysis shows the mean size of the aggregates decreases with increasing concentration of ZnO nanoparticle , which was further confirmed by SEM analysis. UV-Vis and fluorescence spectroscopic studies were performed to analyze the structural changes of lysozyme upon binding with nanoparticles. The congo red assay was performed to study the effects of zinc oxide nanoparticles on lysozyme amyloid fibrils.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
M. Arakha has completed M.Tech. in Biotechnology and Medical Engineering from NIT Rourkela, India. His research area includes nanoscale biophysics, nanobiotechnology and biophysics. Dr. S. Paul is working as a associate professor at NIT Rourkela.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Protein misfolding and aggregation are responsible for several human pathologies commonly known as protein misfolding diseases. The current research work was carried out to investigate the potential of ZnO nanoparticle to prevent lysozyme aggregation. ZnO nanoparticles were synthesized by chemical precipitation method and characterized using different biophysical techniques. The lysozyme aggregation was prepared by heating the native lysozyme at 100 degee Celsius. The effect of ZnO nanoparticles on the aggregation of lysozyme was studied using different biophysical techniques. DLS analysis shows the mean size of the aggregates decreases with increasing concentration of ZnO nanoparticle , which was further confirmed by SEM analysis. UV-Vis and fluorescence spectroscopic studies were performed to analyze the structural changes of lysozyme upon binding with nanoparticles. The congo red assay was performed to study the effects of zinc oxide nanoparticles on lysozyme amyloid fibrils. 52 pp. Englisch. N° de réf. du vendeur 9783659771125
Quantité disponible : 2 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Arakha ManoranjanM. Arakha has completed M.Tech. in Biotechnology and Medical Engineering from NIT Rourkela, India. His research area includes nanoscale biophysics, nanobiotechnology and biophysics. Dr. S. Paul is working as a assoc. N° de réf. du vendeur 151428652
Quantité disponible : Plus de 20 disponibles
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Paperback. Etat : Brand New. 52 pages. 8.66x5.91x0.12 inches. In Stock. N° de réf. du vendeur __3659771120
Quantité disponible : 1 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Protein misfolding and aggregation are responsible for several human pathologies commonly known as protein misfolding diseases. The current research work was carried out to investigate the potential of ZnO nanoparticle to prevent lysozyme aggregation. ZnO nanoparticles were synthesized by chemical precipitation method and characterized using different biophysical techniques. The lysozyme aggregation was prepared by heating the native lysozyme at 100 degee Celsius. The effect of ZnO nanoparticles on the aggregation of lysozyme was studied using different biophysical techniques. DLS analysis shows the mean size of the aggregates decreases with increasing concentration of ZnO nanoparticle , which was further confirmed by SEM analysis. UV-Vis and fluorescence spectroscopic studies were performed to analyze the structural changes of lysozyme upon binding with nanoparticles. The congo red assay was performed to study the effects of zinc oxide nanoparticles on lysozyme amyloid fibrils.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 52 pp. Englisch. N° de réf. du vendeur 9783659771125
Quantité disponible : 1 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Protein misfolding and aggregation are responsible for several human pathologies commonly known as protein misfolding diseases. The current research work was carried out to investigate the potential of ZnO nanoparticle to prevent lysozyme aggregation. ZnO nanoparticles were synthesized by chemical precipitation method and characterized using different biophysical techniques. The lysozyme aggregation was prepared by heating the native lysozyme at 100 degee Celsius. The effect of ZnO nanoparticles on the aggregation of lysozyme was studied using different biophysical techniques. DLS analysis shows the mean size of the aggregates decreases with increasing concentration of ZnO nanoparticle , which was further confirmed by SEM analysis. UV-Vis and fluorescence spectroscopic studies were performed to analyze the structural changes of lysozyme upon binding with nanoparticles. The congo red assay was performed to study the effects of zinc oxide nanoparticles on lysozyme amyloid fibrils. N° de réf. du vendeur 9783659771125
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Investigation on the effect of ZnONP in the aggregation of lysozyme | Manoranjan Arakha (u. a.) | Taschenbuch | 52 S. | Englisch | 2017 | LAP LAMBERT Academic Publishing | EAN 9783659771125 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. N° de réf. du vendeur 108750025
Quantité disponible : 5 disponible(s)